Enteral Nutrition in Neonates on Inotropic Support Admitted to a Tertiary Neonatal Intensive Care Unit: A Prospective Cohort Study.

Background Early initiation of enteral feeding in neonates on inotropic support may improve clinical outcomes compared to intravenous fluids, but the safety and optimal inotrope levels for enteral nutrition remain unclear. This study aims to assess the early initiation of enteral feeding versus intravenous fluids in newborns on inotrope support and to compare the clinical outcome in terms of hospital stay, morbidity, and mortality in neonates with enteral feed versus intravenous (IV) fluid group on inotropes. It also focuses on evaluating the safety of enteral nutrition in neonates with inotropic support and determining the cutoff levels of the inotropes at which enteral feed is well tolerated. Methodology A prospective cohort study was conducted at a tertiary care center in northern Karnataka from June 2022 to December 2023. Neonates born after 28 weeks or more of gestation or weighing more than 1000 grams with fluid nonresponsive shock were enrolled for the study. Neonates with gastrointestinal comorbidities or birth weight below 1000 grams, younger than 28 weeks of gestation, and with lethal congenital malformations were excluded. Eligible neonates were enrolled by the investigator into enteral and intravenous fluid groups at the clinical discretion of the treating neonatologist. Enteral feeding commenced with expressed breast milk or milk from milk bank after 6 hours of stable circulation while the intravenous fluid group received no feed initially. Inotropes were tapered upon stable circulation with feed volumes adjusted based on tolerance. The data obtained was entered into a Microsoft Excel sheet and statistical analyses were performed using IBM SPSS Statistics software, version 20. The results were presented as mean, standard deviation counts, percentages and diagrams. For normally distributed continuous variables between the two groups, they were compared using an independent sample t-test. For not normally distributed variables, the Mann-Whitney U test was used. Categorical variables between the two groups were compared using the chi-square test and Fisher's exact test and p<0.05 was considered statistically significant. Results  The study included 142 neonates (71 per group). The enteral nutrition group had a higher percentage (62; 87.32%) of improved and discharged neonates than the intravenous fluid group (56; 78.87%). The mean time to reach full feeds was significantly lower in the enteral nutrition group (6.04 days) as compared to the intravenous fluid group (9.78 days), with a p-value of < 0.0001. Similarly, the duration of neonatal intensive care unit (NICU) stay was significantly shorter for enteral nutrition group (7.38 days) compared to intravenous fluid group (11.37 days), also with a p-value of < 0.0001. Three patients (4.22%) chose to get discharged against medical advice in the enteral nutrition group while five patients (7.04%) did the same in the intravenous fluid group. The death rate was also higher among intravenous fluid group (10; 10.08%) compared to enteral nutrition group (6; 8.45%). Independent samples t-test showed significant differences in time to reach full feed and duration of NICU stay between cases and controls. Conclusion Neonates receiving enteral feeds had significantly shorter NICU stays, suggesting improved clinical management. Adrenaline (0.1 mcg/kg) with dobutamine (10 mcg/kg) emerged as the optimal inotrope combination for feed tolerance.